Shareholder Votes Against Smoking Ban in Bally's and Boyd Gaming

Regulations by 2FIRSTS.ai
May.21.2024
Shareholder Votes Against Smoking Ban in Bally's and Boyd Gaming
Bally's shareholders reject proposal to ban smoking in 15 casinos, following similar decision by Boyd Gaming investors.

According to a report from The Wall Street Journal on May 20th, shareholders of Bally's Corporation voted against a proposal to ban smoking in its 15 casinos. Additionally, investors in Boyd Gaming have recently made a similar decision.

 

In April of this year, the Michigan-based healthcare system Trinity Health held 440 shares of stock in the Barley Corporation on the New York Stock Exchange, which proposed that Barley consider opening a smoke-free area in its casino. Trinity Health's investment in Barley accounts for 0.001% of the company's portfolio, and as of April, the company has issued a total of 40.5 million shares.

 

According to reports, shareholders of Bally have voted against the proposal to ban smoking in the company's nine casinos. The specific voting results will be disclosed in the upcoming regulatory filings.

 

The management of Bally Company did not comment on the voting results, but they had previously advised shareholders to vote against the proposal because they believed it was "unreasonable and excessive".

 

Prior to the results in Bali, shareholders of Boyd Gaming had already rejected a similar smoking ban proposal made by Trinity Health. Boyd Gaming stated that investors holding 63.6 million shares voted against the proposal, while 18.5 million shares voted in favor.

 

Caesars Entertainment will vote on this proposal at its annual shareholder meeting on June 11, which was also proposed by Tenet Healthcare.

 

Although the proposal by Trident Health was rejected in the ballots in Barry and Boyd, it is not a complete failure. This is because in the Boyd vote, there was over 5% support for implementing a smoking ban, so the issue can be raised again at the 2025 Boyd shareholders meeting. If similar results are seen in the Barry or Caesar votes, Trident Health will bring up the issue again next year.

 

Cynthia Hallett, CEO of the American Nonsmokers' Rights Foundation (ANRF), has participated in shareholder voting and stated, "We have built a very strong foundation from which to work. Most proposals did not even make it to a vote, let alone receive double-digit support. This issue has now reached a level where it can be discussed at the board level, and the company cannot avoid this important topic that affects the health of employees and guests.

 

The American Nonsmokers' Rights Foundation (ANRF) believes that although gambling and smoking have been intertwined for decades, banning smoking in casinos is inevitable. ANRF points out that smoking on commercial flights, once very common, was legislated against in federal regulations in February 1990. ANRF also emphasized the widespread indoor smoking in restaurants and bars in the past. Today, nearly 80% of restaurants in the United States are smoke-free, and the trend toward smoke-free hotels and eliminating smoking rooms continues to rise.

 

The ANRF suggests that with the continued decline in smoking rates and an increasing number of gambling patrons seeking smoke-free environments, today's smoke-free casinos can compete with those that allow smoking.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

 Philip Morris Lowers Profit Outlook as Zyn Faces Competition and FDA Delays
Philip Morris Lowers Profit Outlook as Zyn Faces Competition and FDA Delays
According to Reuters, Philip Morris International (PMI) lowered its 2026 adjusted earnings-per-share forecast amid regulatory uncertainty around Zyn nicotine pouches, rising competition and shipment pressure in the U.S. market.
PMI
Jun.02
FDA Commissioner Marty Makary Resigns After Opposing Trump Administration’s Flavored Vape Push
FDA Commissioner Marty Makary Resigns After Opposing Trump Administration’s Flavored Vape Push
FDA Commissioner Marty Makary resigned on May 12 after opposing the Trump administration’s push to authorize fruit-flavored vaping products, according to reporting by The New York Times. Makary reportedly objected over concerns that flavored vapes could attract young people and refused to support broader approvals.
News
May.13
Nature Health Comment Urges Wider Role for Smoke-Free Nicotine Products in Tobacco Control
Nature Health Comment Urges Wider Role for Smoke-Free Nicotine Products in Tobacco Control
Ahead of World No Tobacco Day, a Nature Health Comment by Robert Beaglehole, Ruth Bonita and Tikki Pang argues that regulated smoke-free nicotine products could help accelerate the global decline in smoking. The authors propose a “smoke-free 2040” goal and call for risk-proportionate regulation distinguishing cigarettes from lower-risk nicotine alternatives.
News
May.20
From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
mperial Brands’ HY26 results point to a more selective NGP transition. The company is using cash flow from traditional tobacco to fund targeted investments in modern oral nicotine, heated tobacco and reusable vaping systems. Its decision to exit the legacy myblu vaping business in the U.S., while expanding Zone nicotine pouches. In Europe, Imperial’s NGP growth is being driven by a multi-category portfolio including blu, Pulze and Zone/Skruf.
Special Report
May.12
Trump’s Tobacco Investments and Industry Donations Draw Scrutiny as FDA Eases Vape and Nicotine Pouch Rules
Trump’s Tobacco Investments and Industry Donations Draw Scrutiny as FDA Eases Vape and Nicotine Pouch Rules
A report by KFF Health News says that as the Trump administration pursued a series of policies favorable to the nicotine and tobacco industry, President Donald Trump increased his holdings in tobacco companies while benefiting from substantial industry-linked political donations, prompting questions from public health advocates about potential conflicts of interest and regulatory direction.
Jun.12
Ispire Reports Fiscal Q3 2026 Revenue of $18.7 Million and Net Loss of $9.5 Million
Ispire Reports Fiscal Q3 2026 Revenue of $18.7 Million and Net Loss of $9.5 Million
Ispire Technology reported financial results on May 7, 2026, for the third quarter of fiscal 2026, covering the three months ended March 31, 2026. Revenue was $18.7 million, compared with $26.2 million in the third quarter of fiscal 2025 and $20.3 million in the prior quarter. Gross profit was $2.0 million, with gross margin of 10.7%. Net loss was $9.5 million, or $0.17 per share. The company said it held $18.0 million in cash as of March 31, 2026, up $468,000 sequentially.
May.08 by 2FIRSTS.ai